» Authors » K Chadwick

K Chadwick

Explore the profile of K Chadwick including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 4192
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stewart J, Breslin W, Beyer B, Chadwick K, De Schaepdrijver L, Desai M, et al.
Ther Innov Regul Sci . 2016 Apr; 50(2):155-168. PMID: 27042398
The Health and Environmental Sciences Institute (HESI) Developmental and Reproductive Toxicology Technical Committee sponsored a pharmaceutical industry survey on current industry practices for contraception use during clinical trials. The objectives...
2.
Thoms J, Dal Pra A, Anborgh P, Christensen E, Fleshner N, Menard C, et al.
Br J Cancer . 2012 Aug; 107(5):840-6. PMID: 22871886
Background: High plasma osteopontin (OPN) has been linked to tumour hypoxia, metastasis, and poor prognosis. This study aims to assess whether plasma osteopontin was a biomarker of increasing progression within...
3.
Murdoch B, Gallacher L, Awaraji C, Hess D, Keeney M, Jay K, et al.
FASEB J . 2001 Jun; 15(9):1628-30. PMID: 11427508
No abstract available.
4.
Bhardwaj G, Murdoch B, Wu D, Baker D, Williams K, Chadwick K, et al.
Nat Immunol . 2001 Mar; 2(2):172-80. PMID: 11175816
A pool of stem cells that arise from the mesoderm during embryogenesis initiates hematopoiesis. However, factors that regulate the expansion of blood stem cells are poorly understood. We show here...
5.
Blankson J, Finzi D, Pierson T, Sabundayo B, Chadwick K, Margolick J, et al.
J Infect Dis . 2000 Nov; 182(6):1636-42. PMID: 11069234
Latent infection of resting CD4(+) T cells represents a major barrier to eradication of human immunodeficiency virus type 1 (HIV-1). The establishment and rate of decay of latent HIV-1 in...
6.
Pierson T, Hoffman T, Blankson J, Finzi D, Chadwick K, Margolick J, et al.
J Virol . 2000 Aug; 74(17):7824-33. PMID: 10933689
Latently infected resting CD4(+) T cells provide a long-term reservoir for human immunodeficiency virus type 1 (HIV-1) and are likely to represent the major barrier to virus eradication in patients...
7.
Chadwick K
Behav Healthc Tomorrow . 2000 Jun; 9(2):37-9. PMID: 10848465
No abstract available.
8.
Finzi D, Blankson J, Siliciano J, Margolick J, Chadwick K, Pierson T, et al.
Nat Med . 1999 May; 5(5):512-7. PMID: 10229227
Combination therapy for HIV-1 infection can reduce plasma virus to undetectable levels, indicating that prolonged treatment might eradicate the infection. However, HIV-1 can persist in a latent form in resting...
9.
Trott K, Lohmann P, Natarajan A, van Zeeland A, Schibilla H, Chadwick K, et al.
Radiat Environ Biophys . 1998 Dec; 37(3):139-42. PMID: 9840481
The present system of radiobiological research in universities and research centres is no longer able to train radiobiologists who have a comprehensive understanding of the entire field of radiation biology...
10.
Finzi D, Hermankova M, Pierson T, Carruth L, Buck C, Chaisson R, et al.
Science . 1997 Nov; 278(5341):1295-300. PMID: 9360927
The hypothesis that quiescent CD4+ T lymphocytes carrying proviral DNA provide a reservoir for human immunodeficiency virus-type 1 (HIV-1) in patients on highly active antiretroviral therapy (HAART) was examined. In...